RT Journal Article
SR Electronic
T1 Tardive dyskinesia in 2 patients treated with ziprasidone
JF Journal of Psychiatry and Neuroscience
JO JPN
FD Canadian Medical Association
SP 467
OP 469
VO 29
IS 6
A1 Jambur Ananth
A1 Karl S. Burgoyne
A1 David Niz
A1 Michael Smith
YR 2004
UL http://jpn.ca/content/29/6/467.abstract
AB Ziprasidone is an atypical antipsychotic drug that is believed to have a low propensity for inducing extrapyramidal symptoms, including tardive dyskinesia (TD). Two of our patients developed TD after 23 months and 34 months of ziprasidone monotherapy, respectively. One of the patients had had earlier exposure to typical antipsychotic drugs, but no other predisposing factors for TD were noted. Therefore, patients on long-term therapy with atypical antipsychotic drugs should be screened periodically for TD.